Research output per year
Research output per year
Personal profile
Specialisation
Medical Oncology
Research interests
Hanneke Wilmink is Professor Medical Oncology at the Amsterdam UMC. She specialises in:
- Upper gastro-intestinal oncology, with a special focus on pancreatic cancer
- Improving the prognosis of pancreatic cancer patients through innovative clinical and translational research
- The clinical trial participants as well as the existing biobank are the main source for the development and validation of prognostic and predictive markers in blood and tumor tissues.
- Dutch Pancreatic Cancer Group: improving outcomes of pancreatic cancer (dpcg.nl)
- Cancer and metabolism
- To develop new therapies with a specific focus on cancer metabolism.
Activities
- Staff member Department of Medical Oncology, Amsterdam UMC
- Board member of the Dutch Pancreatic Cancer Group (DPCG)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Johanna Wilmink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Molenaar, R. J., Radivoyevitch, T. & Wilmink, J. W., 2017, In: Journal of the National Cancer Institute. 109, 8, p. djx103Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile4 Downloads (Pure) -
Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study
Kordes, S., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J. J. G. H. M., van der Vliet, H. J., Kapiteijn, E., van Laarhoven, H. W. M., Richel, D. J., Klinkenbijl, J. H. G., Meijer, S. L. & Wilmink, J. W., 2014, In: International journal of radiation oncology, biology, physics. 90, 1, p. 190-196Research output: Contribution to journal › Article › Academic › peer-review
-
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Kordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J. & Wilmink, J. W., 2015, In: lancet oncology. 16, 7, p. 839-847Research output: Contribution to journal › Article › Academic › peer-review
-
Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies
Deenen, M. J., Klümpen, H.-J., Richel, D. J., Sparidans, R. W., Weterman, M. J., Beijnen, J. H., Schellens, J. H. M. & Wilmink, J. W., 2012, In: Investigational new drugs. 30, 4, p. 1557-1565Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
Rombouts, S. J., Mungroop, T. H., Heilmann, M. N., van Laarhoven, H. W., Busch, O. R., Molenaar, I. Q., Besselink, M. G. & Wilmink, J. W., 2016, In: Journal of Cancer. 7, 13, p. 1861-1866Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure)
Datasets
-
Readily available biomarkers predict poor survival in metastatic pancreatic cancer
Strijker, M. (Creator), van Veldhuisen, E. (Contributor), van der Geest, L. G. (Contributor), Busch, O. R. (Creator), Bijlsma, M. F. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. (Creator), van Hooft, J. E. (Contributor), Verheij, J. (Creator), de Vos-Geelen, J. (Contributor), Wilmink, J. W. (Creator), Steyerberg, W. E. W. (Contributor), Besselink, M. G. (Creator) & van Laarhoven, H. W. (Contributor), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.14169623.v2, https://tandf.figshare.com/articles/dataset/Readily_available_biomarkers_predict_poor_survival_in_metastatic_pancreatic_cancer/14169623/2
Dataset
-
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
Latenstein, A. E. J. (Creator), Mackay, T. M. (Creator), Creemers, G.-J. (Creator), van Eijck, C. H. J. (Creator), de Groot, J. W. B. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. V. (Creator), van Laarhoven, H. W. M. (Creator), Molenaar, I. Q. (Creator), ten Tije, B.-J. (Contributor), de Vos-Geelen, J. (Creator), Besselink, M. G. (Creator), van der Geest, L. G. M. (Creator) & Wilmink, J. W. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.11854743, https://tandf.figshare.com/articles/dataset/Implementation_of_contemporary_chemotherapy_for_patients_with_metastatic_pancreatic_ductal_adenocarcinoma_a_population-based_analysis/11854743/2
Dataset
-
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
Latenstein, A. E. J. (Creator), Mackay, T. M. (Creator), Creemers, G.-J. (Creator), van Eijck, C. H. J. (Creator), de Groot, J. W. B. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. V. (Creator), van Laarhoven, H. W. M. (Creator), Molenaar, I. Q. (Creator), ten Tije, B.-J. (Contributor), de Vos-Geelen, J. (Creator), Besselink, M. G. (Creator), van der Geest, L. G. M. (Creator) & Wilmink, J. W. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.11854743.v2, https://tandf.figshare.com/articles/dataset/Implementation_of_contemporary_chemotherapy_for_patients_with_metastatic_pancreatic_ductal_adenocarcinoma_a_population-based_analysis/11854743/2
Dataset
-
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
Latenstein, A. E. J. (Creator), Mackay, T. M. (Creator), Creemers, G.-J. (Contributor), van Eijck, C. H. J. (Contributor), de Groot, J. W. B. (Contributor), Haj Mohammad, N. (Contributor), Homs, M. Y. V. (Creator), van Laarhoven, H. W. M. (Contributor), Molenaar, I. Q. (Contributor), ten Tije, B.-J. (Contributor), de Vos-Geelen, J. (Contributor), Besselink, M. G. (Creator), van der Geest, L. G. M. (Contributor) & Wilmink, J. W. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.11854743.v1, https://tandf.figshare.com/articles/dataset/Implementation_of_contemporary_chemotherapy_for_patients_with_metastatic_pancreatic_ductal_adenocarcinoma_a_population-based_analysis/11854743/1
Dataset
-
Readily available biomarkers predict poor survival in metastatic pancreatic cancer
Strijker, M. (Creator), van Veldhuisen, E. (Contributor), van der Geest, L. G. (Contributor), Busch, O. R. (Creator), Bijlsma, M. F. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. (Creator), van Hooft, J. E. (Contributor), Verheij, J. (Creator), de Vos-Geelen, J. (Contributor), Wilmink, J. W. (Creator), Steyerberg, W. E. W. (Contributor), Besselink, M. G. (Creator) & van Laarhoven, H. W. (Contributor), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.14169623, https://tandf.figshare.com/articles/dataset/Readily_available_biomarkers_predict_poor_survival_in_metastatic_pancreatic_cancer/14169623
Dataset